These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25446151)

  • 41. Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities.
    Konecny T; Somers VK
    Chest; 2014 Jul; 146(1):228-234. PubMed ID: 25010966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fragmented QRS as a candidate marker for high-risk assessment in hypertrophic cardiomyopathy.
    Kang KW; Janardhan AH; Jung KT; Lee HS; Lee MH; Hwang HJ
    Heart Rhythm; 2014 Aug; 11(8):1433-40. PubMed ID: 24813377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pathology of hypertrophic cardiomyopathy.
    Hughes SE
    Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Late gadolinium enhancement is common in patients with hypertrophic cardiomyopathy and no clinical risk factors for sudden cardiac death: A single center experience.
    Lyons KS; Dixon LJ; Johnston N; Noad R; Hamilton A; McKeag N; Horan P
    Cardiol J; 2014; 21(1):29-32. PubMed ID: 23990187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypertrophic cardiomyopathy: current aspects and new developments].
    Desnos M
    Bull Acad Natl Med; 2012; 196(4-5):997-1009; discussion 1009-10. PubMed ID: 23550458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes after medical and invasive treatment in patients with hypertrophic cardiomyopathy.
    Vriesendorp PA; Liebregts M; Steggerda RC; Schinkel AF; Willems R; Ten Cate FJ; van Cleemput J; Ten Berg JM; Michels M
    JACC Heart Fail; 2014 Dec; 2(6):630-6. PubMed ID: 25447346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypertrophic cardiomyopathy: implications for anesthesia.
    Vives M; Roscoe A
    Minerva Anestesiol; 2014 Dec; 80(12):1310-9. PubMed ID: 24476936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic screening of patients with hypertrophic cardiomyopathy--a new diagnostic strategy for risk stratification?
    Hudecova K; Simkova I; Gardlik R; Bernadic M
    Bratisl Lek Listy; 2009; 110(2):85-92. PubMed ID: 19408839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ
    J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
    Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Autonomic function and severity of hypertrophic cardiomyopathy by power spectrum analysis on heart rate variability].
    Inoue S; Nezuo S; Sawayama T; Hasegawa K; Tamura K; Tanaka J; Nakamura T; Kato T; Ebata J
    Kokyu To Junkan; 1992 Dec; 40(12):1209-13. PubMed ID: 1480833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
    Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
    Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
    Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
    Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
    Orosz A; Baczkó I; Nagy V; Gavallér H; Csanády M; Forster T; Papp JG; Varró A; Lengyel C; Sepp R
    Can J Physiol Pharmacol; 2015 Sep; 93(9):765-72. PubMed ID: 26313025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
    Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence of hypertrophic cardiomyopathy in men: an echocardiographic population screening study with a review of death records.
    Agnarsson UT; Hardarson T; Hallgrimsson J; Sigfusson N
    J Intern Med; 1992 Dec; 232(6):499-506. PubMed ID: 1474350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.